Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 9/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 9/20 | 0.38 |
| ▸ | MAPT | P10636 | 6/20 | 0.38 |
| ▸ | USP2 | O75604 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | TNNI3 | P19429 | 1/20 | 0.38 |
| ▸ | TNNT2 | P45379 | 1/20 | 0.38 |
| ▸ | TNNC1 | P63316 | 1/20 | 0.38 |
| ▸ | CRHBP | P24387 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.38 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.38 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 2/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 3/20 | 0.33 |
| ▸ | IDE | P14735 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.31 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13398977 | 0.86 | — | — | |
| SCHEMBL17445955 | 0.74 | — | — | |
| SCHEMBL17445962 | 0.68 | — | — | |
| SCHEMBL14095020 | 0.67 | — | — | |
| SCHEMBL14539770 | 0.65 | GLO1 (0.49) | MEN1KMT2AMAPTUSP2ALDH1A1 | |
| SCHEMBL19051046 | 0.64 | MAPT (0.39) | MEN1KMT2AMAPTUSP2ALDH1A1 | |
| SCHEMBL17897724 | 0.60 | MEN1 (0.32) | MEN1KMT2AMAPTUSP2THRB | |
| SCHEMBL11572352 | 0.58 | MEN1 (0.40) | MEN1KMT2AMAPTUSP2ALDH1A1 | |
| SCHEMBL12240400 | 0.56 | — | — | |
| SCHEMBL12511129 | 0.54 | MEN1 (0.40) | MEN1KMT2AMAPTUSP2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1549283-B1 | Cosmetic preparation comprising merocyanine derivatives | BASF SE (DE) | 2012-09-12 | — | — | EP | disclosed |
| US-20080260661-A1 | Aminobutadiene-Based Uv Screens | FUJI PHOTO FILM B.V. | 2008-10-23 | — | — | US | disclosed |
| US-20080260661-A1 | Aminobutadiene-Based Uv Screens | FUJI PHOTO FILM B.V. | 2008-10-23 | — | — | US | disclosed |
| US-7407648-B2 | Merocyanine derivatives for cosmetic use | CIBA SPECIALTY CHEMICALS CORP. (US) | 2008-08-05 | — | — | US | disclosed |
| US-7407648-B2 | Merocyanine derivatives for cosmetic use | CIBA SPECIALTY CHEMICALS CORP. (US) | 2008-08-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080260661-A1 | Aminobutadiene-Based Uv Screens | ALAD, AAAS, ALDH7A1 | MEN1 1641/4885KMT2A 2884/4885MAPT 1149/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.